Citations

Showing 1-23 of 23
Journal Article
Iwuji, C. C, J. Iwuji, J. Larmarange, E. Balestre, R. Thiebaut, F. Tanser, N. Okesola, T. Makowa, J. Dreyer, K. Herbst, N. McGrath, T. Barnighausen, S. Boyer, T. De Oliveira, C. Rekacewicz, B. Bazin, M. L Newell, D. Pillay, F. Dabis, and Anrs TasP Study Group. "Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial." Lancet HIV 5, no. 3 (2018): e116-e125.
Journal Article
Fiorentino, M., M. Nishimwe, C. Protopopescu, C. Iwuji, N. Okesola, B. Spire, J. Orne-Gliemann, N. McGrath, D. Pillay, F. Dabis, J. Larmarange, and S. Boyer. "Early ART Initiation Improves HIV Status Disclosure and Social Support in People Living with HIV, Linked to Care Within a Universal Test and Treat Program in Rural South Africa (ANRS 12249 TasP Trial)." AIDS Behav 25, no. 4 (2021): 1306-1322.
Journal Article
Gosset, A., C. Protopopescu, J. Larmarange, J. Orne-Gliemann, N. McGrath, D. Pillay, F. Dabis, C. Iwuji, and S. Boyer. "Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial)." J Acquir Immune Defic Syndr 80, no. 4 (2019): 375-385.
Journal Article
Collier, D., C. Iwuji, A. Derache, T. de Oliveira, N. Okesola, A. Calmy, F. Dabis, D. Pillay, R. K Gupta, French National Agency for, Aids, and Viral Hepatitis Research 12249 Treatment as Prevention Study, Group. "Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis." Clin Infect Dis 64, no. 8 (2017).
Journal Article
Ngwenya, N., C. Iwuji, N. Petersen, N. Myeni, S. Nxumalo, U. Ngema, and J. Seeley. "Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews." (2021) J Med Ethics.
Journal Article
Havlir, D., S. Lockman, H. Ayles, J. Larmarange, G. Chamie, T. Gaolathe, C. Iwuji, S. Fidler, M. Kamya, S. Floyd, J. Moore, R. Hayes, M. Petersen, F. Dabis, and U. T Consortium. "What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?." J Int AIDS Soc 23, no. 2 (2020).
Journal Article
Iwuji, C., N. McGrath, A. Calmy, F. Dabis, D. Pillay, M. L Newell, K. Baisley, and K. Porter. "Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial." J Int AIDS Soc 21, no. 6 (2018).
Journal Article
Siedner, M. J, G. Harling, A. Derache, T. Smit, T. Khoza, R. Gunda, T. Mngomezulu, D. Gareta, N. Majozi, E. Ehlers, J. Dreyer, S. Nxumalo, N. Dayi, G. Ording-Jesperson, N. Ngwenya, E. Wong, C. Iwuji, M. Shahmanesh, J. Seeley, T. De Oliveira, T. Ndung'u, W. Hanekom, and K. Herbst. "Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-Natal." (2020) Wellcome Open Res.
Journal Article
Iwuji, C. C, M. Shahmanesh, O. Koole, K. Herbst, D. Pillay, M. J Siedner, K. Baisley, and H. Dream Network. "Clinical outcomes after first-line HIV treatment failure in South Africa: the next cascade of care." HIV Med 21, no. 7 (2020).
Journal Article
Siedner, M. J, J. D Kraemer, M. J Meyer, G. Harling, T. Mngomezulu, P. Gabela, S. Dlamini, D. Gareta, N. Majozi, N. Ngwenya, J. Seeley, E. Wong, C. Iwuji, M. Shahmanesh, W. Hanekom, and K. Herbst. "Access to primary healthcare during lockdown measures for COVID-19 in rural South Africa: a longitudinal cohort study." (2020) medRxiv.
Journal Article
Orievulu, K. S, and C. C Iwuji. "Institutional Responses to Drought in a High HIV Prevalence Setting in Rural South Africa." Int J Environ Res Public Health 19, no. 1 (2021).
Journal Article
Iwuji, C., R. S Chimukuche, T. Zuma, M. Plazy, J. Larmarange, J. Orne-Gliemann, M. Siedner, M. Shahmanesh, and J. Seeley. "Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa." PLoS One 15, no. 9 (2020).
Journal Article
Yapa, H. M, H. Y Kim, K. Petoumenos, F. A Post, A. Jiamsakul, J. W De Neve, F. Tanser, C. Iwuji, K. Baisley, M. Shahmanesh, D. Pillay, M. J Siedner, T. Barnighausen, and J. Bor. "CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis." Clin Infect Dis 74, no. 8 (2022): 1350-1359.
Journal Article
Larmarange, J., M. H Diallo, N. McGrath, C. Iwuji, M. Plazy, R. Thiebaut, F. Tanser, T. Barnighausen, J. Orne-Gliemann, D. Pillay, F. Dabis, and Anrs TasP Study Group. "Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa." J Int AIDS Soc 22, no. 10 (2019).
Journal Article
Larmarange, J., M. H Diallo, N. McGrath, C. Iwuji, M. Plazy, R. Thiebaut, F. Tanser, T. Barnighausen, D. Pillay, F. Dabis, J. Orne-Gliemann, and Anrs TasP Study Group. "The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)." (2018) J Int AIDS Soc.
Journal Article
Yapa, H. M, H. Kim, K. Petoumenos, F. A Post, A. Jiamsakul, J. De Neve, F. Tanser, C. Iwuji, K. Baisley, and M. Shahmanesh. "CD4+ T-cell count at antiretroviral therapy initiation in the “treat-all” era in rural south africa: an interrupted time series analysis." Clinical Infectious Diseases 74, no. 8 (2022): 1350-1359.
Journal Article
Baisley, K., J. Orne‐Gliemann, J. Larmarange, M. Plazy, D. Collier, J. Dreyer, T. Mngomezulu, K. Herbst, W. Hanekom, F. Dabis, M. J Siedner, and C. Iwuji. "Treat‐all strategy and long‐term survival among people living with HIV in South Africa: Results after 6 years of observation in the ANRS 12249 treatment as prevention trial.." HIV MED.
Journal Article
Baisley, K., J. Orne‐Gliemann, J. Larmarange, M. Plazy, D. Collier, J. Dreyer, T. Mngomezulu, K. Herbst, W. Hanekom, F. Dabis, M. J Siedner, and C. Iwuji. "Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial." HIV Medicine 23, no. 8 (2022): 922-928.
Journal Article
Sabapathy, K., L. Balzer, J. Larmarange, L. Block, S. Floyd, C. Iwuji, K. Wirth, H. Ayles, S. Fidler, M. Kamya, M. Petersen, D. Havlir, F. Dabis, J. Moore, and R. Hayes. "Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa." BMC Public Health 22, no. 1 (2022).
Journal Article
Plazy, M., A. Diallo, T. Hlabisa, N. Okesola, C. Iwuji, K. Herbst, S. Boyer, F. Lert, N. McGrath, D. Pillay, F. Dabis, J. Larmarange, and J. Orne-Gliemann. "Implementation and effectiveness of a linkage to HIV care intervention in rural South Africa (ANRS 12249 TasP trial)." PLOS ONE 18, no. 1 (2023).
Journal Article
Iwuji, C., M. Osler, L. Mazibuko, N. Hounsome, N. Ngwenya, R. S Chimukuche, T. Khoza, D. Gareta, H. Sunpath, A. Boulle, and K. Herbst. "Optimised electronic patient records to improve clinical monitoring of HIV-positive patients in rural South Africa (MONART trial): study protocol for a cluster-randomised trial." BMC Infectious Diseases 21, no. 1 (2021).
Journal Article
Baisley, K. J, J. Seeley, M. J Siedner, K. Koole, P. Matthews, F. Tanser, T. Barnighausen, T. Smit, D. Gareta, S. Dlamini, K. Herbst, Y. Hm, I. Cc, and K. Hy. "Findings from home-based HIV testing and facilitated linkage after scale-up of test and treat in rural South Africa: young people still missing." HIV Med 20, no. 10 (2019): 704-708.
Showing 1-23 of 23